Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 33, 1999 - Issue 203
Submit an article Journal homepage
19
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Prostate Cancer in Denmark: Incidence, Morbidity and Mortality

Klaus Brasso, Peter Iversen Department of Urology D-2111, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100 Denmark
Pages 29-33 | Published online: 09 Jul 2009

REFERENCES

  • Jonsson P. Danneskiold-Samsoe B, Heggestad T, Iversen P. Leisti S. Management of early prostatic cancer in the Nordic countries: variations in clinical policies and physicians attitudes towards radical treat-ment options. Int J Tech Ass 1995; 11: 66–78.
  • Iversen P. Prostate cancer. Editorial. Ugeskr Leger 1997; 159: 2519 (in Danish).
  • Storm H, Manders T, Lecker S. Cancer incidence in Denmark 1991. Copenhagen: Danish Cancer Registry, 1994.
  • Moller H, Mellemgaard A, Lindvig K, Olsen J. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994; 30A: 344–50.
  • The Danish National Board of Health. Evaluation of the Danish Hospital Discharge Registry, 2nd edd. Copenha-gen: The Danish National Board of Health, 1993.
  • Brasso K, Friis S, Kjwr SK, Jorgensen T, Iversen P. Prostate cancer in Denmark: a 50-year population-based study. Urology 1998; 51: 590–4.
  • Hakama M, Hakulinen T. Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chron Dis 1997; 30: 585–97.
  • Prener A, Kjwr S. Prostate cancer in Denmark. Ugeskr Leger 1987; 149: 1705–7 (in Danish).
  • Harvei S, Tretli S, Langmark F. Cancer of the prostate in Norway 1957–1991. A descriptive study. Eur J Cancer 1996; 32A: 111–7.
  • Whittemore A. Prostate cancer. Cancer Surveys 1994; 19/20: 309–22.
  • Lu-Yao G, Greenberg E. Changes in prostate incidence and treatment in USA. Lancet 1994; 343: 1211–16.
  • Potosky A, Miller B, Albertsen P, Kramer B. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995; 273: 548–52.
  • Albertsen P. Fryback D, Storer B, Kolon T, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995; 274: 626–31.
  • Chodak G, Thisted R, Gerber G, Johansson J, Adolfsson J, Jones G, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330: 242–8.
  • Johansson J, Holmberg L, Johansson S, Bergstrom R, Adami H. Fifteen-year survival in prostate cancer. JAMA 1997; 277: 467–71.
  • McLaren DB, McKenzie M, Duncan G, Pickles T. Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma. Cancer 1998; 82: 342–8.
  • Aus G, Hugosson J, Norlen L. Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. J Urol 1995; 154: 466–9.
  • Bone M, Nerstrom B, Overgaard J. Prostate cancer-an expensive dilemma. Ugeskr Leger 1997; 159: 2534–7 (in Danish).
  • Carlsson P. Hjertberg H, Jonsson B, Varenhorst E. The cost of prostatic cancer in a defined population. Scand J Urol Nephrol 1989; 23: 93–6.
  • Handley R, Can W, Powell P, Hall R. Deferred treatment for prostate cancer. Br J Urol 1988; 62: 249–53.
  • Otnes B, Harvei S, Fossa. S. The burden of prostate cancer from diagnosis to death. Br J Urol 1995; 76: 587–94.
  • Cullen D, Apolone G, Greenfield S, Guadagnoli E, Cleary P. ASA physical status and age predict morbidity after three surgical procedures. Ann Surg 1994; 220: 3–9.
  • Thorpe A, Cleary P, Coles J, Vernon S, Reynolds J, Neal D. Deaths and complications following prostatectomy in 1400 men in the Northern Region of England. Br J Urol 1994; 74: 559–65.
  • Adami H-0, Norlen BJ, Malker B, Meirik O. Long-term survival in prostatic carcinoma, with special reference to age as prognostic factor. Scand J Urol Nephrol 1986; 20: 107–12.
  • Bone M, Nerstrom B, Overgaard J. The natural history of prostate carcinoma based on a Danish cancer population treated with no intent to cure. Cancer 1997; 80: 917–28.
  • Gronberg H, Damber J, Jonsson H, Lenner P. Patient age as a prognostic factor in prostate cancer. J Urol 1994; 152: 892–5.
  • gronberg H, Bergh A, Damber J, Jonsson H, Lenner P. Angstrom T. Prostate cancer in Northern Sweden. Acta Oncologica 1994; 33: 359–63.
  • Helgesen F, Holmberg L, Johansson J, Bergstrom R, Adami H. Trends in prostate cancer survival in Sweden 1960 through 1988: evidence of increasing detection of nonlethal tumors. J Natl Cancer Inst 1996; 88: 1216–21.
  • Moller H, Friis S, Kjwr K. Survival of Danish cancer patients. Male genital organs. APMIS 1993; 101 Suppl 3: 122–36.
  • Stattin P. Bergh A, Karlberg L, Tavelin B, Damber J. Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancer. Eur J Urol 1997; 32: 404–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.